Truvestments Capital LLC Ani Pharmaceuticals Inc Transaction History

Truvestments Capital LLC

$363 Million
Q3 2024

A detailed history of Truvestments Capital LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Truvestments Capital LLC holds 267 shares of ANIP stock, worth $15,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares

267

Holding current value

$15,048

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$54.33 - $65.72 $14,506 - $17,547	267 New	267 $15,000
Q1 2024 May 14, 2024	SELL	$54.2 - $69.69 $6,558 - $8,432	-121 Reduced 31.19%	267 $18,000
Q2 2023 Aug 10, 2023	BUY	$37.29 - $53.83 $4,512 - $6,513	121 Added 45.32%	388 $20,000
Q1 2023 May 12, 2023	SELL	$37.61 - $45.72 $4,550 - $5,532	-121 Reduced 31.19%	267 $10,000
Q2 2022 Aug 09, 2022	BUY	$23.09 - $33.46 $8,958 - $12,982	388 New	388 $12,000
Q1 2022 May 02, 2022	SELL	$26.91 - $47.15 $10,441 - $18,294	-388 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$23.69 - $31.47 $9,191 - $12,210	388 New	388 $11,000
Q3 2020 Nov 13, 2020	SELL	$26.38 - $33.1 $26,591 - $33,364	-1,008 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$29.93 - $50.1 $16,880 - $28,256	-564 Reduced 35.88%	1,008 $32,000
Q1 2020 May 07, 2020	BUY	$30.35 - $67.14 $47,710 - $105,544	1,572 New	1,572 $64,000
Q4 2019 Jan 29, 2020	SELL	$55.65 - $79.83 $125,824 - $180,495	-2,261 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$67.77 - $82.2 $19,043 - $23,098	281 Added 14.19%	2,261 $186,000
Q1 2019 Apr 12, 2019	SELL	$45.83 - $70.54 $32,355 - $49,801	-706 Reduced 26.28%	1,980 $140,000
Q3 2018 Oct 22, 2018	BUY	$52.95 - $71.34 $142,223 - $191,619	2,686 New	2,686 $152,000

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account

Truvestments Capital LLC Ani Pharmaceuticals Inc Transaction History